🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Glaukos Corporation

GKOS Healthcare
$112.77 +$0.13 (0.12%)
Market Cap: $6.55 B
Gurus Holding
4
Popularity Rank
#2462
% of Shares Held
0.32%
Net Activity (Q4 2025)
-$64.07 M

Guru Ownership Trend

Guru Analysis for Glaukos Corporation (GKOS)

Glaukos Corporation (GKOS), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $20.7 M.

Top institutional holders include Steven Cohen and Cliff Asness.

Institutional sentiment is currently Bearish. This is evidenced by a $64.07 M net outflow during the quarter.

Recent activity highlights Joel Greenblatt who opened a new position. Conversely, Steven Cohen reduced exposure by 76.6%.

Key Holders

Top 5 by Value

$18.25 M
$1.76 M
$417,880
$301,018

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$894,356.16
Total Buy Value
New Buys 1
Additions 1
-$64.96 M
Total Sell Value
Reductions 2
Sold Out 1

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
3
Net Buyers
2

FAQs for Glaukos Corporation (GKOS)

Major holders include Steven Cohen ($18.25 M), Cliff Asness ($1.76 M), Mario Gabelli ($417,880). According to the latest reported data, 4 tracked investment managers collectively hold approximately 183,535 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $64.07 M, with 2 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited GKOS. The total reported sell value was $64.96 M.

Yes, 1 managers opened new positions in GKOS, and 1 increased their existing holdings. The total reported buy value was $894,356.16.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.02% Reduce -76.6% 161,596 $18.25 M Q4 2025
0.00% Add 50.9% 15,572 $1.76 M Q4 2025
0.00% Reduce -54.3% 3,701 $417,880 Q4 2025
0.00% New Buy 2,666 $301,018 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form